Blue Trust’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Blue Trust's MEDP Position: Q3 2026 in Review
Blue Trust reduced its Medpace (MEDP) stake by 20% in Q3 2026, selling an estimated $94.9K and leaving 649 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #546.
Blue Trust first reported a position in MEDP in Q2 2022 and has held it in 18 quarters since. The position peaked at $430K in Q2 2026. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Blue Trust held 649 shares of Medpace worth $405K as of Q3 2026.
- Blue Trust sold 162 Medpace shares in Q3 2026, an estimated $94.9K.
- Medpace made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #546 holding.
- Blue Trust first reported a position in Medpace in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Medpace position peaked at $430K in Q2 2026.
- 619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.